- ￥5800
- GeneTex
- 美国
- GTX60676
- 2025年07月16日
- WB, FACS, ELISA
- Mouse
- Human, Rat
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Purified recombinant fragment of human VE-Cadherin (AA: 29-223 ) expressed in E. Coli.
- 亚型：
IgG1
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human, Rat
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Human
- 目录编号：
GTX60676
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Mouse
- 应用范围：
WB, FACS, ELISA
- 浓度：
1 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点：
VE-Cadherin
- 抗体英文名：
VE-Cadherin antibody [3D5C7]
- 抗体名：
VE-Cadherin 抗体 [3D5C7]
- 规格：
100 μg
WB analysis of MCF-7 (1), A549 (2), HUVE-12 (3) cell lysate, and rat lung (4) tissue lysate using GTX60676 VE-Cadherin antibody [3D5C7].
ELISA analysis of antigen using GTX60676 VE-Cadherin antibody [3D5C7].
Black : Control antigen 100ng
Purple : Antigen 10ng
Blue : Antigen 50ng
Red : Antigen 100ng
FACS analysis of Jurkat cells using GTX60676 VE-Cadherin antibody [3D5C7].
Green : VE-Cadherin
Purple : negative control
WB analysis of human CDH5 recombinant protein using GTX60676 VE-Cadherin antibody [3D5C7].
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验补体成分 C6/C7/C8/C9 补体成分：C6 血清浓度(μg/ml)：60 分子量(kDa)：128 亚单位(链)及分子量(kDa)：1条 生物学活性：组成MAC，触发淋巴细胞母细胞化 补体成分：C7 血清浓度(μg/ml)：60 分子量(kDa)：121 亚单位(链)及分子量(kDa)：1条
against cholera vibrios could transfer immunity to na�ve animals, and also kill the bacteria in vitro (1 ). However, although antitoxin antibodies rapidly found clinical application, there was little understanding regarding the nature of the antibody molecule
Construction of Semisynthetic Antibody Libraries
ve B-cell repertoires (3 –6 ), germline sequences (7 ) or immunized donors (8 ), it is also possible to make use of the available information on antibody structure to generate diversity by including short stretches of random sequences in carefully
技术资料暂无技术资料 索取技术资料
